The fight against HIV has seen remarkable advances, particularly with the development of broadly neutralizing antibodies (bnAbs) that can target diverse strains of the virus. However, delivering these antibodies efficiently and sustainably…
Transient rapamycin treatment enables long-term delivery of anti-HIV antibodies
